Grifols considers a potential US IPO of its US biopharma unit as part of its self-sufficiency plan. Read more here.
Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a potential US IPO of its shares of its US biopharma business.
The company said it was making the move as part of its “self-sufficiency program.”
Grifols noted there is n… [311 chars]
Source: Seeking Alpha | Published: 2026-03-24T21:40:23Z
Credit: Seeking Alpha
